Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Bod Australia Ltd ( (AU:BOD) ) has shared an update.
Bod Science Limited is undergoing a Deed of Company Arrangement (DOCA) with Biortica Agrimed Limited, which was executed in April 2024. The DOCA period has been extended to June 2025 due to delays in meeting ASX requirements, and an extraordinary general meeting will be scheduled once conditions are met.
More about Bod Australia Ltd
Bod Science Limited, formerly known as Bod Australia Limited, operates in the pharmaceutical and healthcare industry, focusing on the development and distribution of health and wellness products.
YTD Price Performance: 20.0%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$4.26M
Learn more about BOD stock on TipRanks’ Stock Analysis page.